EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism

Sophie Rhys-Evans iD, Francesco d'Aniello, Emma C Alexander iD, Ibrahim F Dinah, Sabine Heger, Anna Nordenstrom, Julia Rohayem, Sasha R Howard iD

The Journal of Clinical Endocrinology & Metabolism · 17.03.2025 · 110 (4) · e921-e931

DOI: 10.1210/clinem/dgae874 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 14.12.2024. Verfasst von Sophie Rhys-Evans und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ London, UK. Hauptthemen laut MEDLINE: Hypogonadism, Gonadotropins, Sexual Maturation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Erasmus+, Academic Clinical Fellowship, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Congenital hypogonadotropic hypogonadism (CHH) is defined as an isolated deficiency of gonadotropin hormones. Mini-puberty, a transient postnatal activation of the hypothalamic-pituitary-gonadal axis in healthy infants, provides a window of opportunity to diagnose and treat CHH. Currently, in male infants with CHH, testosterone is used to increase phallus size. However, gonadotropin replacement could additionally promote testicular descent and development, particularly relating to Sertoli cells. We conducted a systematic review of the effectiveness of gonadotropin therapy in stimulating mini-puberty related outcomes in male infants with CHH. Evidence Acquisition In line with PRISMA guidelines, a systematic review of 11 databases was carried out (August 2023). Evidence quality was assessed using the Cochrane Risk of Bias for Non-Randomised Studies of Interventions tool. Protocol registered on PROSPERO (CRD42023453080). Evidence Synthesis After a double-consensus screen of 767 abstracts and 66 full texts, 11 studies were included from 7 countries. A total of 71 male infants were enrolled, 12 with Kallmann syndrome. Median age at treatment initiation was 4.2 months (range, 0.25-57 months) and follow-up ranged from 3 to 10 years. Gonadotropin therapy was administered using continuous subcutaneous infusion (n = 35) or subcutaneous injection (n = 36). Due to treatment variability, modalities were combined for data synthesis. Gonadotropins induced a statistically significant increase in penile length and inhibin B concentration (P = .0007) and led to partial or full testicular descent in 73% (n = 62) of patients.

Conclusion

This systematic review provides unique evidence supporting the efficacy of gonadotropins for induction of mini-puberty. However, the reliability and generalizability are limited due to disparate data and treatment modality variation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismGonadotropinsSexual MaturationHumansMaleInfantChild, PreschoolInfant, Newborn

Stichwörter der Autor:innen

congenital hypogonadotropic hypogonadismfertilitygonadotropin deficiencygonadotropin treatmentmini-puberty

Substanzen

Gonadotropins

Autor:innen und Institutionen

  • Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ London, UK.
  • School of Pediatrics, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Endocrinology and Diabetes Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London W2 1NY, UK.
  • Paediatric Endocrine Unit, Social Paediatric Centre AUF DER BULT, 30173 Hannover, Germany.
  • Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.

ORCID-Profile: Sophie Rhys-Evans, Emma C Alexander, Sasha R Howard

Förderung

  • Erasmus+
  • Academic Clinical Fellowship
  • Wellcome Trust
  • National Institute for Health and Care Research
  • National Health Service
  • European Society of Paediatric Endocrinology
  • Barts Charity
  • UK Department of Health and Social Care

Zitieren

APA

Rhys-Evans, S., d'Aniello, F., Alexander, E. C., Dinah, I. F., Heger, S., Nordenstrom, A., Rohayem, J., & Howard, S. R. (2025). Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism. The Journal of Clinical Endocrinology & Metabolism, 110(4), e921-e931. https://doi.org/10.1210/clinem/dgae874

Vancouver

Rhys-Evans S, d'Aniello F, Alexander EC, Dinah IF, Heger S, Nordenstrom A, et al. Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism. The Journal of Clinical Endocrinology & Metabolism. 2025;110(4):e921-e931. doi:10.1210/clinem/dgae874

BibTeX
@article{RhysEvans2025,
  author = {Rhys-Evans, Sophie and d'Aniello, Francesco and Alexander, Emma C and Dinah, Ibrahim F and Heger, Sabine and Nordenstrom, Anna and Rohayem, Julia and Howard, Sasha R},
  title = {Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {4},
  pages = {e921--e931},
  doi = {10.1210/clinem/dgae874}
}
Kostenlos starten →